新西兰允许在医疗活动中发布未经批准的药品广告,以促进创新和经济增长。 New Zealand allows advertising unapproved medicines at medical events to boost innovation and economic growth.

新西兰在通过《药品修正法案》之后,取消了在医疗会议和贸易展上刊登未经批准的药品广告的限制,目的是促进经济增长和符合国际标准。 New Zealand has lifted restrictions on advertising unapproved medicines at medical conferences and trade shows after passing the Medicines Amendment Bill, aiming to boost economic growth and align with international standards. 预计这一变化将产生9 000万美元的收入,并吸引2026年两次大型澳洲医疗会议,将带来3 300名代表,并改善获得新治疗的机会。 The change, expected to generate $90 million in revenue and attract two major Australasian medical conferences in 2026, will bring about 3,300 delegates and improve access to emerging treatments. 官方表示这项行动支持医疗创新、专业发展及患者结果, Officials say the move supports healthcare innovation, professional development, and patient outcomes while maintaining safety oversight.